REVIEW 7 cited by
PharmAgents: Building a Virtual Pharma with Large Language Model Agents
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
read the original abstract
The discovery of novel small molecule drugs remains a critical scientific challenge with far-reaching implications for treating diseases and advancing human health. Traditional drug development--especially for small molecule therapeutics--is a highly complex, resource-intensive, and time-consuming process that requires multidisciplinary collaboration. Recent breakthroughs in artificial intelligence (AI), particularly the rise of large language models (LLMs), present a transformative opportunity to streamline and accelerate this process. In this paper, we introduce PharmAgents, a virtual pharmaceutical ecosystem driven by LLM-based multi-agent collaboration. PharmAgents simulates the full drug discovery workflow--from target discovery to preclinical evaluation--by integrating explainable, LLM-driven agents equipped with specialized machine learning models and computational tools. Through structured knowledge exchange and automated optimization, PharmAgents identifies potential therapeutic targets, discovers promising lead compounds, enhances binding affinity and key molecular properties, and performs in silico analyses of toxicity and synthetic feasibility. Additionally, the system supports interpretability, agent interaction, and self-evolvement, enabling it to refine future drug designs based on prior experience. By showcasing the potential of LLM-powered multi-agent systems in drug discovery, this work establishes a new paradigm for autonomous, explainable, and scalable pharmaceutical research, with future extensions toward comprehensive drug lifecycle management.
Forward citations
Cited by 7 Pith papers
-
MolLingo: Molecule-Native Representations for LLM-Powered Scientific Agents
MolLingo introduces a multi-agent framework with BFE molecular representation and docking-grounded reasoning to outperform frontier LLMs on molecular design benchmarks including fourfold docking score gains.
-
Camyla: Scaling Autonomous Research in Medical Image Segmentation
Camyla autonomously generates research proposals, experiments, and manuscripts in medical image segmentation, outperforming baselines on 24 of 31 recent datasets while producing 40 human-reviewed papers.
-
Mol-Debate: Multi-Agent Debate Improves Structural Reasoning in Molecular Design
Mol-Debate applies multi-agent debate in an iterative loop with perspective orchestration to achieve state-of-the-art text-guided molecular design, scoring 59.82% exact match on ChEBI-20 and 50.52% weighted success on...
-
Evaluating Agentic Bioinformatics through Function, Evidence, and Validation
Agentic bioinformatics systems mostly demonstrate planning and tool execution but rarely prospective empirical validation, so the paper argues evaluation should center on inspectable workflow trajectories (FEV) rather...
-
Beyond SMILES: Evaluating Agentic Systems for Drug Discovery
Drug-discovery AI agents are built for small-molecule, big-pharma settings and lack peptide, in vivo, training-loop, small-lab, and multi-objective capabilities, even though LLMs themselves can reason about peptides.
-
An Auditable Agent Platform For Automated Molecular Optimisation
A hierarchical multi-agent LLM platform with recorded provenance improved average predicted binding affinity for AKT1 by 31%, while single-agent runs favored drug-likeness.
-
Agents in the Wild: Where Research Meets Deployment
A tutorial description reviewing the state of LLM agent deployment, with no new research findings.
Discussion (0). Sign in to comment.